State Of Wisconsin Investment Board Crinetics Pharmaceuticals, Inc. Transaction History
State Of Wisconsin Investment Board
- $36.9 Billion
- Q4 2024
A detailed history of State Of Wisconsin Investment Board transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 75,103 shares of CRNX stock, worth $2.49 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,103
Previous 65,394
14.85%
Holding current value
$2.49 Million
Previous $3.34 Million
14.97%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding CRNX
# of Institutions
254Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$302 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$231 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$207 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$204 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$180 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.79B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...